Canada How close are we to a coronavirus vaccine?

15:28  02 august  2020
15:28  02 august  2020 Source:   globalnews.ca

Tam says feds, experts discussing COVID-19 vaccine orders amid concerns of delay

  Tam says feds, experts discussing COVID-19 vaccine orders amid concerns of delay OTTAWA — Canada's chief medical officer Dr. Theresa Tam says active discussions are taking place to potentially pre-order COVID-19 vaccine doses for Canadians. Tam says an independent vaccine task force is advising the government on options for Canada's choice of vaccine, including exploring the possibility of manufacturing a potential pandemic cure at home. Tam was addressing concerns that Canadians will have to get in line behind other countries to wait for the COVID-19 vaccine.

The coronavirus spreads easily and the majority of the world's population is still vulnerable to it. A vaccine would provide some protection by training

There’s a vaccine that might protect against the new coronavirus stored in a freezer in Texas. Yes, that’s the virus that’s killed more than 500 people and infected The vaccine was developed in the early 2010s, by a team led by Peter Hotez and Maria Elena Bottazzi at the Baylor College of Medicine.

a man in a blue shirt: Nurse Carolyn Grausgruber gives volunteer Ithaca firefighter Wade Bardo, of Erin, N.Y., an injection as the world's biggest study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway Monday, July 27, 2020, in Binghamton, N.Y. © AP Photo/Hans Pennink Nurse Carolyn Grausgruber gives volunteer Ithaca firefighter Wade Bardo, of Erin, N.Y., an injection as the world's biggest study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway Monday, July 27, 2020, in Binghamton, N.Y.

Millions of dollars and hundreds of hours of researchers’ time have been invested in the hunt for a vaccine for the novel coronavirus.

Russia promises mass vaccination against Covid for October

 Russia promises mass vaccination against Covid for October SANT-CORONAVIRUS-RUSSIA-VACCINE: Russia promises mass vaccination against Covid for October © Reuters / Maxim Shemetov RUSSIA PROMISES FOR OCTOBER A VACCINATION OF MASS AGAINST COVID PARIS (Reuters) - Russia's health minister is preparing a mass vaccination campaign against the novel coronavirus for October, local news agencies report on Saturday after a vaccine candidate has finished its clinical trials.

Vaccines normally require years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine within In phase 1 of clinical testing, the vaccine is given to a small group of people to determine whether it is safe and to learn more about the immune response

So how long could that take? We ’re going to look at the current state of the science in the race to find a vaccine for coronavirus . London: human trials to begin this summer. A separate project led by Professor Robin Shattock of Imperial College London is close to the human testing phase.

It’s paying off – experts say we could see the first vaccines approved by the end of 2020, but there’s still a lot of questions that need to be answered before you roll up your sleeve. These include how well it works, which shot we use, and who gets first crack at the new vaccine.

Where research stands

In late July, some manufacturers announced promising early results. A vaccine candidate developed by researchers at Oxford University in the U.K. appeared to cause an immune response with minimal side effects. A joint Canadian and Chinese project also announced that they were moving forward with further testing, after seeing some success.

Read more: Here’s when experts say Oxford University’s coronavirus vaccine could be ready

Corona Vaccination: Hopeful News! Vaccine faster than expected?

 Corona Vaccination: Hopeful News! Vaccine faster than expected? © provided by WUNDERWEIB Researchers all over the world are working feverishly on a corona vaccine. When will there be a Corona vaccine? Experts are now making a forecast that gives hope. The number of corona infections has been rising again for a few weeks and there are always local outbreaks in Germany. Many fear that there will be a second corona wave. All the more he hopes that there will soon be a vaccine against the virus.

As Covid-19 cases spike in some countries, it’s clear that the pandemic isn’t slowing down. That’s why many are pinning their hopes on a vaccine .

Mar.17 -- World Economic Forum Head of Global Health and Healthcare Arnaud Bernaert discusses global containment measures and a timeframe for development of

According to the World Health Organization, there are currently 165 vaccine candidates being studied worldwide. Five of those are in Stage 3 clinical trials – typically the last stage, after which the vaccine could be approved if it shows positive results.

One of those, by the company Moderna, is now being tested in thousands of people across the U.S., in a trial that started Monday.

Read more: World’s largest coronavirus vaccine study kicks off in U.S.

“I think it's pretty exciting that a number of vaccines have moved on to this phase,” said Dr. Manish Sadarangani, an assistant professor at the University of British Columbia and director of the Vaccine Evaluation Centre at B.C. Children’s Hospital.

“I think it’s actually incredible to think that, given that normally vaccine development takes 10 to 15 years at least, that we’ve done several years’ worth of development in the space of a few months.”

Canada’s coronavirus restrictions could last years even with vaccine: top doctors

  Canada’s coronavirus restrictions could last years even with vaccine: top doctors Top doctor's comments come as polling suggests many Canadians fear unproven side effects.In a briefing with journalists Tuesday, Chief Public Health Officer Dr. Theresa Tam warned against basing all hope for a return to normalcy on the creation of a vaccine for the deadly virus.

We 've detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. As long as the virus lurks in people’s throats and on elevator panels, doorknobs, and subway-car poles, it is hard to see how

The World Health Organisation (WHO) has released an updated list of vaccines under development for COVID-19, with the number of candidates under clinical evaluation stage rising to 17 from just five a month ago. Though the number has gone up, the vaccines are in various stages of trial.

Manufacturers were able to move so quickly in part because they’re building upon other vaccines, he said. “It’s not quite plug-and-play,” he said, but manufacturers were able to take existing vaccines and swap out a few pieces to try to match them to the SARS-CoV-2 virus rather than starting from scratch.

Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, told Congress Friday that he’s hoping for one or two successful vaccines by late fall or early winter.

While some experts have said it will take longer, others like Craig Jenne, an associate professor in microbiology, immunology and infectious diseases at the University of Calgary, believe it’s possible.

“I do believe that we will see one and maybe even two vaccines approved both by the FDA and by the European Regulatory Agency before the end of the calendar year,” he said.

“That doesn't mean that January 1st we can get vaccinated.”

Safe and effective

Health Canada will want to review safety data itself and approve a vaccine on its own judgment, rather than just applying “a rubber stamp” to whatever the U.S. approves, Jenne said. This will take some time.

Pfizer announces deal to supply Canada with coronavirus vaccine candidate

  Pfizer announces deal to supply Canada with coronavirus vaccine candidate The global race for a vaccine is on and countries are expected to face fierce competition for supplies.The announcement came in the form of a tweet an hour before markets opened and two hours before a scheduled announcement from the Canadian government about vaccine procurement that is set to take place at 10 a.m.

The last vaccine which is close to being rolled out is being developed by the University of Melbourne in conjunction with the Murdoch Children’s Research Institute. UK coronavirus lab chief Professor Robin Shattock says vaccine could be rolled out early next year.

How much would a coronavirus vaccine cost? This has not been firmly established. The aid group Médecins Sans Frontières -- or Doctors Without Borders -- has urged world leaders to demand pharmaceutical companies sell any successful Are we sure we 'll get an effective Covid-19 vaccine ?

Sadarangani doesn’t believe there is any reason to be concerned about the speed of the research. “I think, to be honest, the follow up of participants in the trials has been very rigorous. These are people who are followed up very closely to look for side effects,” he said.

COVID-19 vaccines will still have to provide safety and efficacy data the same way as any other vaccine in order to be approved, he said. This includes monitoring for side effects even after it hits the market, as there might be very specific groups of people who experience side effects from the shot, which weren’t identified in trials.

Read more: Researchers ‘very confident’ vaccine for coronavirus will be developed

The vaccine won’t necessarily be 100 per cent effective in preventing COVID-19 either.

“The WHO has set the bar at 50 per cent,” said Dr. Brian Ward, an infectious diseases professor at Montreal's McGill University and medical director of Medicago, a Canadian vaccine manufacturer that is working on its own vaccine candidate.

“A vaccine that is 50 per cent effective will be considered a good enough vaccine to move forward.”

The measles vaccine, considered an extremely effective vaccine, is about 97 per cent effective with two doses, the CDC says. The flu shot varies between 40 to 60 per cent.

Canada signs deals with Pfizer, Moderna to get doses of COVID-19 vaccines

  Canada signs deals with Pfizer, Moderna to get doses of COVID-19 vaccines OTTAWA — Canada is negotiating deals with pharmaceutical giant Pfizer and U.S.-based biotech firm Moderna to secure millions of doses of their experimental COVID-19 vaccines, in case either is approved for wide-scale use. But Procurement Minister Anita Anand won't say yet how much Canada is spending or how many doses of either vaccine candidate Canada will get because she says Canada is in talks with other domestic and international firms to secure doses of their experimental vaccines as well.

Even a partially effective vaccine would allow us to get back to something closer to pre-pandemic life, Ward said. There’s another advantage too: it’s likely that even if the shot doesn’t fully protect someone, it will still drastically cut down the chance of severe illness if they do catch the virus.

Read more: Flu shot protected most people from infection during unusual influenza season

This happens with the flu shot, he said, where your symptoms are likely reduced, even if it doesn’t always keep you from catching the flu. “If we can reduce SARS coronavirus to being like the other human coronaviruses where it's like a cold, that would also be certainly good enough.”

Getting the shot

Even after a shot is approved, it could still take a while before it’s generally available, experts say.

First of all, there are likely to be several vaccine formulations that get approved, said Jenne, who also holds a Canada Research Chair.

“As an immunologist, I very much hope that we get more than one answer,” he said.

Having several different vaccines would be a good thing, he said, as some might be more suited to give to vulnerable populations like people with pre-existing conditions or the elderly. It’s also possible that an individual might be able to get even better immunity by taking several shots.

Read more: As rich nations prepare for coronavirus vaccine, others could be left behind

The other reason we need many different vaccines approved worldwide, or at least made worldwide, comes down to manufacturing capacity, Ward said.

Trump appearances in movies and TV shows

  Trump appearances in movies and TV shows Trump appearances in movies and TV shows

“Almost all of the vaccines that are in clinical trials are testing two doses, and most of them are likely to need two doses based on animal data to date. So that means that if we're going to vaccinate the world at 7.8 billion people, we're going to need 15.6 billion doses of vaccine.”

Even the pharmaceutical giants are only talking about producing 500 million doses per year, meaning it would take years to vaccinate everyone unless there are many different vaccines being made, he said.

Some countries, such as the U.S., have already made deals with pharmaceutical companies to secure supplies of an eventual vaccine, leaving smaller countries like Canada further down the list.

Read more: U.K. signs deal to buy 90 million doses of experimental coronavirus vaccine

“If you're talking about trying to vaccinate huge numbers of people across the globe, then I think the timeline is going to be a bit longer,” Sadarangani said.

“I don't think it's going to be a one-off: suddenly there's a vaccine and everyone's going go and get it the next week.

“I think it's going to be a sequential thing where there’s decisions that need to be made about how to prioritize the use of the vaccines, and who should get the vaccine first, who's at the highest risk of getting severe disease. And then who gets it in subsequent production batches.”

Gallery: Ticks and mosquitoes: These insects transmit diseases (Espresso)

a insect on the plant: Summer is the perfect time for outdoor activities like camping and swimming, but beware of bugs! Some insects can transmit diseases that can be serious or even fatal.Getting sick from a mosquito bite is more common than you might think. The number of cases of illness transmitted by insects in the United States tripled to more than 640,000 between 2004 and 2016, according to a CDC report.

Curevac IPO should bring up to 245 million dollars .
© Sebastian Gollnow / dpa The biotech company Curevac goes public - that should bring in up to 245 million US dollars. The planned US IPO of the biotech company Curevac, which is researching a corona vaccine, is expected to bring in up to 245 million US dollars (around 209 million euros). The company announced that it was initially planned to offer and sell a good 13.3 million ordinary shares.

—   Share news in the SOC. Networks
usr: 5
This is interesting!